ORGANIZATION

• Pharma Leaders Rev Up Lobbying Campaigns ahead of Year-End Budget, Tax Debates
  November 18, 2015

• FPMAJ Gives Up on Crafting Rules for Disclosing Joint Generic Developers
  October 27, 2015

• Reflect Industry Opinions in Pilot Introduction of Cost-Effective Assessments: JPMA
  October 27, 2015

• JPMA Says Its Demands Generally Accepted in TPP, No Impact Expected on Japan Market
  October 23, 2015

• EFPIA Poised to Lobby Japan on Vaccine Regulations in EPA Talks
  October 22, 2015

• AMDJ to Draw Up Voluntary Rules for Managing Big Data in Field of Healthcare
  October 14, 2015

• ACCJ Applauds Conclusion of TPP Talks
  October 8, 2015

• EFPIA Vice President Has High Hopes for Japan’s Innovation
  October 7, 2015

• EFPIA Director General Welcomes Broad Deal Reached on TPP
  October 7, 2015

• JPMA President Congratulates Nobel Laureate Omura
  October 7, 2015

• Drug Pricing Tomorrow: Full Interview with JMA Vice President Nakagawa
  October 5, 2015

• New 3 Price-Band Rule Will Boost Predictability, Foster Healthy Competition: JGA Officials
  October 2, 2015

• “Humanitarian Trials” Not Welcomed but Well-Designed: JPMA Regulatory Chief
  September 30, 2015

• JPWA Asks LDP Bigwigs to Simplify Market Price Survey for Tax Hike If Conducted at All
  September 30, 2015

• Drug Pricing Tomorrow: JMA’s Nakagawa Says Price Maintenance Premium Should Continue as Trial Measure
  September 29, 2015

• April-June Generic Share at 54.4%: JGA
  September 28, 2015

• Kenporen Proposal Prods Health Coverage Removal for “1st-Generation Poultices”
  September 25, 2015

• JPMA Reprimands Pfizer over Failure to Report ADRs
  September 18, 2015

• JPMA Helping Member Firms Expand into Emerging Asian Markets: Int’l Affairs Chief
  September 17, 2015

• JPMA Policy Research Unit Sets Up Study Group on Big Data
  September 10, 2015

ページ

• « 先頭
• ‹ Prev
• …
• 50
• 51
• 52
• 53
• 54
• 55
• 56
• 57
• 58
• …
• Next ›
• 最終 »